Seroprevalence of hepatitis C virus infection in nigerians with type 2 diabetes mellitus

Nigerian Journal of Clinical Practice

Volumn 11, Issue 3, 2008, Pages 199-201

  Adegoke, O A ^a   Kolawole, B A ^a   Ikem, R T ^a   Adediran, A ^a   Aboderin, A O ^a   Salawu, A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

Author keywords

Hcv infection; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; BLOOD; CASE CONTROL STUDY; COMORBIDITY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

CASE-CONTROL STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NIGERIA; SEROEPIDEMIOLOGIC STUDIES;

EID: 59449108900     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. The Expert Committee on Non-communicable Disease. Non-Communicable Disease in Nigeria. Final report of a national survey, Federal Ministry of Health, Lagos 1997.
2. Diabetes cases in Africa to double in next 25 years. Bull World Health Organization, ISSN 0042-9686, May 2004, vol.82, no.5, p.397-398
3. Ojo OS, Thursz M, Thomas HC, Ndububa DA, Adeodu OO, Rotimi O et al. Hepatitis B virus markers, hepatitis DI virus antigen and hepatitis C Virus antibodies in Nigerian patients with chronic liver disease E. Afri. Med. J.1995; 72; 719-721
4. 4. Ndububa DA, Ojo OS, Adetiloye VA , Duresimi MA, Olasode BJ, Famurewa OC et al Chronic hepatitis in Nigerian patients, a study of 70 biopsy proven cases WA JM 2005; 24:107-111. (Pubitemid 41057363)
5. Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. The effect of HAART and HCV infection on the development of hyperglycaemia among HIVinfectedpersons. JAIDS2002,; 33:577-584.
6. 6. Bahtiyar G, Shin JJ. Ataman A, Sowers RJ, Mcfarlane SI, etal. Association of diabetes and hepatitis C infection, Epidemiologic evidence and pathophysiologic insights: Curr Diab.Rep. 2004; 4:194-198 (Pubitemid 38899149)
7. Khalili M, Lim. JN, Bass N, Ascher NL, Roberts JP, Tenault NA et al. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis infection: Liver TranspL2004,10:349-355
8. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach. Dig Liver Dis. 2006 Jul 31 ; [Epub ahead of print]
9. 9. Balogun WO, Adeleye JO, Akinlade KS, Kuti M, Otegbayo JA. Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital. J Natl Med Assoc. 2006; 98:1805-1808 (Pubitemid 44885537)
10. Simo R, Hernanderz C, Genesca J. High prevalence of hepatitis C Virus infection in diabetic patients: Diabetes care 1996:19: 9981000.
11. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Makuudi M, Kimura S et al. Hepatitis C Virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126:917-919
12. 12. Wilson C. Hepatitis C infection and type 2 diabetes in American-Indian women. Diabetes care 2004;27:2116-2119 (Pubitemid 39167172)
13. 13. Narita R, Abe S, Kihara Yeta 1. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J. Hepatol 2004; 41:132-138 (Pubitemid 39005164)
14. Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am. J. Gastroenterol 2004;99:286291.